10-Q Filing

BNB PLUS CORP. CIK: 744452 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001410578-25-000126`
Period End Date	20241231
Filing Date	20250213
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	apdn-20241231x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 158 Income Statement 80 Cash Flow Statement 92 Stockholders Equity 36

Balance Sheet 158 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$82.72K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$82.72K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.43M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.29M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance for credit losses of $82,723 and $75,000 at December 31, 2024 and September 30, 2024, respectively	`AccountsReceivableNetCurrent`	$362.01K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $82,723 and $75,000 at December 31, 2024 and September 30, 2024, respectively	`AccountsReceivableNetCurrent`	$362.01K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $82,723 and $75,000 at December 31, 2024 and September 30, 2024, respectively	`AccountsReceivableNetCurrent`	$911.50K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $82,723 and $75,000 at December 31, 2024 and September 30, 2024, respectively	`AccountsReceivableNetCurrent`	$911.50K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$438.59K	USD	Point-in-time
Inventories	`InventoryNet`	$438.59K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$468.58K	USD	Point-in-time
Inventories	`InventoryNet`	$468.58K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$815.97K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$815.97K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$601.51K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$601.51K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.28M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.28M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$553.23K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$553.23K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$638.48K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$638.48K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.11M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.11M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$607.29K	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$607.29K	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$739.16K	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$739.16K	USD	Point-in-time
Total assets	`Assets`	$12.79M	USD	Point-in-time
Total assets	`Assets`	$12.79M	USD	Point-in-time
Total assets	`Assets`	$15.97M	USD	Point-in-time
Total assets	`Assets`	$15.97M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.61M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.61M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$545.91K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$545.91K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$558.43K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$558.43K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$217.22K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$217.22K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$58.78K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$58.78K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$193.25K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$193.25K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$48.86K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$48.86K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$76.00K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$76.00K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$320.00K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$320.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.42M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.42M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.82M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.82M	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2024 and September 30, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2024 and September 30, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2024 and September 30, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2024 and September 30, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2024 and September 30, 2024, 54,111,523 and 10,311,885 shares issued and outstanding as of December 31, 2024 and September 30, 2024, respectively	`CommonStockValue`	$54.11K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2024 and September 30, 2024, 54,111,523 and 10,311,885 shares issued and outstanding as of December 31, 2024 and September 30, 2024, respectively	`CommonStockValue`	$54.11K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2024 and September 30, 2024, 54,111,523 and 10,311,885 shares issued and outstanding as of December 31, 2024 and September 30, 2024, respectively	`CommonStockValue`	$10.31K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2024 and September 30, 2024, 54,111,523 and 10,311,885 shares issued and outstanding as of December 31, 2024 and September 30, 2024, respectively	`CommonStockValue`	$10.31K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$339.92M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$339.92M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$318.81M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$318.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-309.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-309.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-327.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-327.22M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$12.75M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$12.75M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-174.53K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-174.53K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-203.83K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-203.83K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$12.79M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$12.79M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$15.97M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$15.97M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.20M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.20M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$891.16K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$891.16K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$512.51K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$512.51K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$660.07K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$660.07K	USD	1 Quarter
Gross profit	`GrossProfit`	$684.11K	USD	1 Quarter
Gross profit	`GrossProfit`	$684.11K	USD	1 Quarter
Gross profit	`GrossProfit`	$231.10K	USD	1 Quarter
Gross profit	`GrossProfit`	$231.10K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.63M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.63M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$935.82K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$935.82K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.02M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.02M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.65M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.96M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.96M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.79M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.79M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$33.32K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$33.32K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$71.44K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$71.44K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-244.00K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-244.00K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-2.64M	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-2.64M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-20.15K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-20.15K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-13.54K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-13.54K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.13M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.13M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.67M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.67M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.67M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.67M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.13M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.13M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-29.30K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-29.30K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-25.18K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-25.18K	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.64M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.64M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$14.91M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$14.91M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$77.76K	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$77.76K	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.18M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.18M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.55M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.55M	USD	1 Quarter
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-0.56	USD	1 Quarter
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-0.56	USD	1 Quarter
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-1.73	USD	1 Quarter
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-1.73	USD	1 Quarter
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.73	USD	1 Quarter
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.73	USD	1 Quarter
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.56	USD	1 Quarter
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.56	USD	1 Quarter
Weighted average shares outstanding- basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	683,672.00	shares	1 Quarter
Weighted average shares outstanding- basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	683,672.00	shares	1 Quarter
Weighted average shares outstanding- basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.52M	shares	1 Quarter
Weighted average shares outstanding- basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.52M	shares	1 Quarter
Weighted average shares outstanding- diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.52M	shares	1 Quarter
Weighted average shares outstanding- diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.52M	shares	1 Quarter
Weighted average shares outstanding- diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	683,672.00	shares	1 Quarter
Weighted average shares outstanding- diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	683,672.00	shares	1 Quarter

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$298.95K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$298.95K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$58.58K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$58.58K	USD	1 Quarter
Loss on write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$5.29K	USD	1 Quarter
Loss on write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$5.29K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$2.64M	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$2.64M	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$244.00K	USD	1 Quarter
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$244.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$28.97K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$28.97K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$340.70K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$340.70K	USD	1 Quarter
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$7.72K	USD	1 Quarter
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$7.72K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$195.25K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$195.25K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$557.21K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$557.21K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$47.26K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$47.26K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$29.99K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$29.99K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-214.46K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-214.46K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.71K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.71K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-383.42K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-383.42K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-299.62K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-299.62K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$11.60K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$11.60K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$158.43K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$158.43K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.76M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.76M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.33M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.33M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$116.88K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$116.88K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-116.88K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-116.88K	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$508.60K	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$508.60K	USD	1 Quarter
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.80M	USD	1 Quarter
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.80M	USD	1 Quarter
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$45.57K	USD	1 Quarter
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$45.57K	USD	1 Quarter
Capitalized transaction costs	`PaymentsOfStockIssuanceCosts`	$80.64K	USD	1 Quarter
Capitalized transaction costs	`PaymentsOfStockIssuanceCosts`	$80.64K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-35.08K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-35.08K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.31M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.31M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.79M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.79M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.86M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.86M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.04M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Transaction costs included in accounts payable	`CapitalizedTransactionCostsIncludedInAccountsPayable`	$136.91K	USD	1 Quarter
Transaction costs included in accounts payable	`CapitalizedTransactionCostsIncludedInAccountsPayable`	$136.91K	USD	1 Quarter
Transaction costs included in accounts payable	`CapitalizedTransactionCostsIncludedInAccountsPayable`	$84.92K	USD	1 Quarter
Transaction costs included in accounts payable	`CapitalizedTransactionCostsIncludedInAccountsPayable`	$84.92K	USD	1 Quarter
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$14.91M	USD	1 Quarter
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$14.91M	USD	1 Quarter
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$77.76K	USD	1 Quarter
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$77.76K	USD	1 Quarter
Warrants issued, cashlessly	`FairValueOfWarrantsIssued`	$20.92K	USD	1 Quarter
Warrants issued, cashlessly	`FairValueOfWarrantsIssued`	$20.92K	USD	1 Quarter
Property and equipment acquired and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$32.24K	USD	1 Quarter
Property and equipment acquired and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$32.24K	USD	1 Quarter

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Exercise of warrants	`StockIssuedDuringPeriodValueUponExerciseOfWarrants`	$508.60K	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueUponExerciseOfWarrants`	$508.60K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$340.70K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$340.70K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.97K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.97K	USD	1 Quarter
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs	`SharesAndPreFundedWarrantsIssuedInRegisteredDirectOfferingNet`	$5.71M	USD	1 Quarter
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs	`SharesAndPreFundedWarrantsIssuedInRegisteredDirectOfferingNet`	$5.71M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.55M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	54.11M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.